Quan Venture Fund II, L.P. 4
4 · Design Therapeutics, Inc. · Filed Apr 1, 2021
Insider Transaction Report
Form 4
Quan Venture Fund II, L.P.
10% Owner
Transactions
- Conversion
Common Stock
[F1]2021-03-30+4,439,839→ 4,439,839 total - Conversion
Common Stock
[F1]2021-03-30+280,991→ 4,720,830 total - Conversion
Series A Preferred Stock
[F1]2021-03-30−7,236,938→ 0 total→ Common Stock (4,439,839 underlying) - Conversion
Series B Preferred Stock
[F1]2021-03-30−458,016→ 0 total→ Common Stock (280,991 underlying)
Footnotes (1)
- [F1]All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one share of Common Stock for each 1.63 shares of Preferred Stock, based on the conversion price currently in effect. The Preferred Stock has no expiration date.
Signature
QUAN VENTURE FUND II, L.P., By: QUAN VENTURE PARTNERS II, L.L.C., its general partner, By: /s/ Stella Xu, Managing Director|2021-03-31